Lv41
430 积分 2026-04-04 加入
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m2 but without diabetes: A phase 2 randomized controlled trial
19分钟前
求助中
Mazdutide, a dual agonist targeting GLP-1R and GCGR, mitigates diabetes-associated cognitive dysfunction: mechanistic insights from multi-omics analysis
41分钟前
已完结
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
1小时前
已完结
Mazdutide versus placebo in Chinese adults with type 2 diabetes
1小时前
已完结
IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose phase 1b study
1小时前
求助中
Ma Q, Qian L. A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
1小时前
已完结
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes
1小时前
已完结
GLORY-1 Investigators. Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
1小时前
已完结
A sensitive approach for simultaneous quantification of carbonyl and hydroxyl steroids using 96-well SPE plates based on stable isotope coded-derivatization-UPLC-MRM: method development and application
1小时前
已完结
Targeted UPLC-MS/MS high-throughput metabolomics approach to assess the purine and pyrimidine metabolism
1小时前
已完结
皖公网安备34019202002308
